• Join
  • Login
  • Contact

Health and Medicines Information Section

About us and our objectives

FIP’s Health and Medicines Information Section (HaMIS; previously known as the Pharmacy Information Section) was founded in 1951 at FIP’s 14th general assembly in Rome. The membership has gradually broadened to include pharmacists and pharmaceutical scientists from all over the globe who are interested in information related to health and medicines across a number of different capacities.

HAMIS members map

A global map depicting the countries where HaMIS members are from

HaMIS endeavours to offer:

  • A forum to share knowledge about information issues relating to pharmacy, medicines, medical conditions and health, including public health;
  • Avenues for networking between groups providing information and information services to patients and health care professionals;
  • Avenues for networking between groups conducting research related to health and medicines information; and
  • Opportunities to enhance public health and the work of the pharmacy profession through information programmes and related initiatives.

Health and medicines information underpins pharmacy practice across all disciplines. Areas of interest include:

  • Strategic development of medicines information;
  • Pharmacists as health and medicines information experts;
  • Information needs of health care professionals, patients and consumers; 
  • Development, dissemination, and use of health and medicines information to help optimise patient care, pharmaceutical care and public health;
  • Patient empowerment;
  • Health and medicines information as a tool to improve medication adherence;
  • Health literacy;
  • Development of health information technology and information delivery;
  • Novel formats of health care communication, inclusive of social media, mHealth, Internet resources and other electronic resources;
  • Writing and publishing health and medicines information resources;
  • Medicine and poisons information services;
  • Pharmacovigilance efforts;
  • Global access to health care information;
  • Medicines formulary information development; and
  • Advertising and promotion of medicines.

How we work

Every four years, officers of FIP’s Health and Medicines Information Section (HaMIS) are elected. They include a President, Secretary and Treasurer. The Executive Committee consists of these three officers, the Immediate Past President, and three to six Section members elected to provide geographical balance. The current Executive Committee (2016-20) comprises the following members:


Prof. Parisa Aslani (Australia)Prof. Parisa Aslani


Dr Boyan Todorov (Netherlands)Dr Boyan Todorov


Ms Lindsay McClure (United Kingdom)Ms Lindsay McClure
(United Kingdom)

Representative for Africa/Middle East

Mr Wael Kamel Ali Ali Mazrouh (Egypt)Mr Wael Kamel Ali Ali Mazrouh

Representative for the Americas

Prof. Victoria Hall Ramírez (Costa Rica)Prof. Victoria Hall Ramírez
(Costa Rica)

Representative for Asia/Pacific

Dr Vivien Tong (Australia)Dr Vivien Tong

Representative for Europe

Ms Rian Lelie- van der Zande (Netherlands)Ms Rian Lelie- van der Zande

In addition to these positions, there are two Representative-at-Large positions, which do not necessarily represent a certain region of the world. Both positions are currently vacant.

The current statutes of the Health and Medicines Information Section were adopted by the FIP Council in 2014. Click to download the HaMIS statutes in PDF format.


Annual report

The HaMIS annual report is available here.

Last update 15 May 2019

FIP Congresses